Imelda Parker

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 173 citations · Full text

Medicine, Oncology, Perioperative Medicine +16

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

Brian O’Neill, S M Griffin, C. Mariette et al. · BMC Cancer · 2017 · 159 citations · Full text

Medicine, Oncology, Surgery +17

Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).

John V. Reynolds, Shaun R. Preston, Brian O’Neill et al. · Journal of Clinical Oncology · 2021 · 115 citations

Medicine, Oncology, Radiation Oncology +17

The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer

Khairun I. Abdul-Jalil, Katherine M. Sheehan, Joan Kehoe et al. · Colorectal Disease · 2013 · 47 citations

Medicine, Radiation Oncology, Surgery +17

(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis

K. A. Lee, Mary Dunne, Cormac Small et al. · Acta Oncologica · 2018 · 35 citations · Full text

Medicine, Oncology, Radiation Oncology +14